Let's see how Inavir competes with Tamiflu in the Japan market in the following year.
Currently 0 of inavir stockpiled the Japanese government. There has to been some stockpile orders for Inavir, IMO.
Good luck. Let's see how BOTA does tonight. If Biota was still on ASX, we should have seen at least 10% rise of the share price.